BRCA1 and BRCA2 expression patterns and prognostic significance in digestive system cancers
New research in Human Pathology finds BRCA1 and BRCA2 can be used as clinicopathological biomarkers to assess the prognosis of gastric cancer.
Read SourceNew research in Human Pathology finds BRCA1 and BRCA2 can be used as clinicopathological biomarkers to assess the prognosis of gastric cancer.
Read SourceFor press inquiries about the Gastric Cancer Foundation, please contact: Mediainfo@gastriccancer.org
Together, we will defeat stomach cancer.
Together, we will defeat stomach cancer.
MORE INFODONATE